Treatment success rate: previously treated TB cases in Tajikistan
Tajikistan: Treatment success rate: previously treated TB cases was 81 in 2023. ▲ Rising
Latest (2023)
81
Change on year
up 2.5%
World rank
54th
of 179 countries
All-time high
83
in 2017
All-time low
56
in 2001
Years of data
22
2001–2023
Treatment success rate: previously treated TB cases in Tajikistan, 2001–2023
Source: World Health Organization, Global Health Observatory.
Analysis
In 2023, treatment success rate: previously treated tb cases in Tajikistan stood at 81.
That represents a change of up 2.5% on the previous year and down 1.2% over ten years.
Over the whole period, treatment success rate: previously treated tb cases in Tajikistan peaked at 83 in 2017 and was at its lowest, 56, in 2001.
Tajikistan ranks 54th of 179 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 22 years of available data.
Treatment success rate: previously treated TB cases in Tajikistan, year by year
| Year | Value | Change |
|---|---|---|
| 2001 | 56 | — |
| 2003 | 67 | +19.6% |
| 2004 | 74 | +10.4% |
| 2005 | 76 | +2.7% |
| 2006 | 73 | -3.9% |
| 2007 | 75 | +2.7% |
| 2008 | 76 | +1.3% |
| 2009 | 72 | -5.3% |
| 2010 | 72 | +0.0% |
| 2011 | 71 | -1.4% |
| 2012 | 75 | +5.6% |
| 2013 | 82 | +9.3% |
| 2014 | 82 | +0.0% |
| 2015 | 80 | -2.4% |
| 2016 | 81 | +1.2% |
| 2017 | 83 | +2.5% |
| 2018 | 82 | -1.2% |
| 2019 | 80 | -2.4% |
| 2020 | 80 | +0.0% |
| 2021 | 83 | +3.8% |
| 2022 | 79 | -4.8% |
| 2023 | 81 | +2.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 71.12 | 56 | 76 | 8 |
| 2010s | 78.8 | 71 | 83 | 10 |
| 2020s | 80.75 | 79 | 83 | 4 |
Countries ranked near Tajikistan
- 51 Nepal 82 compare
- 51 United Kingdom of Great Britain and Northern Ireland 82 compare
- 51 Venezuela, Bolivarian Republic of 82 compare
- 55 Lao People's Democratic Republic 80 compare
- 55 Hungary 80 compare
- 57 Niger 79 compare
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.5415 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1769 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.9367 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1817 units per person (2025)
Frequently asked questions
- What is treatment success rate: previously treated tb cases in Tajikistan?
- Treatment success rate: previously treated tb cases in Tajikistan was 81 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: previously treated tb cases recorded in Tajikistan?
- The highest recorded value was 83 in 2017.
- What is the lowest treatment success rate: previously treated tb cases recorded in Tajikistan?
- The lowest recorded value was 56 in 2001.
- How does Tajikistan rank for treatment success rate: previously treated tb cases?
- Tajikistan ranks 54th out of 179 countries with data for 2023.
- Is treatment success rate: previously treated tb cases rising or falling in Tajikistan?
- Over the last ten years it is down 1.2%. The long-run trend across the full record is rising.
- Where does this Tajikistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: previously treated TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).